Legal Opinion
Bristol-Myers Squibb Co. v. Superior Court of Cal., San Francisco Cty.
Supreme Court of the United States
Decided June 19, 2017No. 16–466PublishedCited by 2,311 opinions
1Opinion of the CourtJustice Alito
More than 600 plaintiffs, most of whom are not California residents, filed this civil action in a California state court against Bristol-Myers Squibb Company (BMS), asserting a variety of state-law claims based on injuries allegedly caused by a BMS drug called Plavix. The California Supreme Court held that the California courts have specific jurisdiction to entertain the nonresidents' claims. We now reverse.
I
A
BMS, a large pharmaceutical company, is incorporated in Delaware and headquartered in New York, and it maintains substantial *1778operations in both New York and New Jersey. 1 Cal.5th 783,…
2Cases cited16 opinions
- International Shoe Co. v. WashingtonSupreme Court of the United States · 1945
- Burger King Corp. v. RudzewiczSupreme Court of the United States · 1985
- World-Wide Volkswagen Corp. v. WoodsonSupreme Court of the United States · 1980
- Hanson v. DencklaSupreme Court of the United States · 1958
- Helicopteros Nacionales De Colombia, S. A. v. HallSupreme Court of the United States · 1984
11 more not listed; retrieve them via the Exa API.
3Cited by2,311 opinions
- Axiom Foods, Inc. v. Acerchem International, Inc.Court of Appeals for the Ninth Circuit · 2017
- SPV Osus Ltd. v. UBS AGCourt of Appeals for the Second Circuit · 2018
- Charles Curry v. Revolution Laboratories, LLCCourt of Appeals for the Seventh Circuit · 2020
- Old Republic Insurance Co. v. Continental Motors, Inc.Court of Appeals for the Tenth Circuit · 2017
- Walter Shuker v. Smith & Nephew PLCCourt of Appeals for the Third Circuit · 2018
2,306 more not listed; retrieve them via the Exa API.